Steven Galson, MD, has been appointed acting surgeon general beginning October 1, 2007.
Steven Galson, MD, has been appointed acting surgeon general beginning October 1, 2007. Galson, a Rear Admiral with the US Public Health Service, joined the FDA in April 2001 as the Center for Drug Evaluation and Research (CDER) deputy center director and was appointed director in July 2005. Janet Woodcock, MD, will become acting director at CDER until a permanent center director is found. She will retain her position as deputy commissioner and permanent chief medical officer.
Guidance on Quality Culture Standards
June 3rd 2025Matt Cushing, VP of Quality and Science, Nelson Labs, and Susan J. Schniepp, distinguished fellow at Regulatory Compliance Associates, a Nelson Labs Company, discuss PDA/ANSI Standard 06-2025: Assessment of Quality Culture Guidance Documents, Models, and Tools, which was published in February 2025.